… In the present report, we describe the clinical course of patients with papillary thyroid
cancer in whom disease recurred after initial therapy with surgery and radioactive iodine (MI) …

… Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory outcomes.
However, 8%–28% of patients with PTC show tumor recurrence, which may affect prognosis. …

… no mortality was observed during followup, but relatively shorter follow-up period for papillary
thyroid cancer in our patients should be considered. Recurrence ratio was found as 12.9%. …

… in cancer care, but it is unknown as to what extent insurance status affects treatments
provided to papillary thyroid cancer (PTC) patients. We hypothesized that insured patients with …

… incidence of thyroid cancer in China has increased significantly over the past two decades
[1]. Papillary thyroid cancer (PTC) is the most common histologic subtype of thyroid cancer, …

Simple Summary Aggressive metastatic disease is rare in papillary thyroid carcinoma (PTC),
a neoplasia that usually carries an excellent prognosis. BRAF, RAS, and TERT promoter (…

Objectives To determine the diagnostic accuracy of ultrasound (US), CT and their combination
in detecting cervical lymph node metastasis (CLNM) in patients with papillary thyroid …

… Papillary thyroid cancer (PTC) accounts for approximately 85% of well-differentiated
thyroid cancer.1 PTC is generally indolent, with a 93% cause-specific 10-year survival.2 …

… The current use of life-long follow-up in patients with papillary thyroid cancer (PTC) is based
largely on the study of individuals diagnosed and treated in the latter half of the 20th century …

… of thyroid cancer has tripled over the past 3 decades, with the vast majority of the increase
noted to be among small, indolent papillary thyroid … of thyroid cancer is slowing. Because …